Therefore, we identify the upstream molecular mechanism by which deacetylation stimulates TFEB induction of lysosomal biogenesis to enhance microglial degradation of fAβ and reduction of amyloid plaques, suggesting a novel strategy for treatment of AD. The gene discussed is FANCB; the disease is Alzheimer disease.